nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—MB21D1—conduct disorder	0.1	0.128	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—MB21D1—conduct disorder	0.0948	0.121	CbGpPWpGaD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—POLR3A—conduct disorder	0.0735	0.0941	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—POLR3A—conduct disorder	0.0695	0.089	CbGpPWpGaD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—EP300—conduct disorder	0.0495	0.0633	CbGpPWpGaD
Olopatadine—S100A2—p73 transcription factor network—EP300—conduct disorder	0.0365	0.0467	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—EP300—conduct disorder	0.0231	0.0295	CbGpPWpGaD
Olopatadine—HRH1—Monoamine GPCRs—DRD4—conduct disorder	0.0199	0.0254	CbGpPWpGaD
Olopatadine—Cyclobenzaprine—HTR2A—conduct disorder	0.0179	0.125	CrCbGaD
Olopatadine—S100A12—Innate Immune System—MB21D1—conduct disorder	0.0177	0.0226	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MB21D1—conduct disorder	0.0167	0.0214	CbGpPWpGaD
Olopatadine—HRH1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0167	0.0214	CbGpPWpGaD
Olopatadine—S100A2—brain—conduct disorder	0.0167	0.222	CbGeAlD
Olopatadine—S100A1—brain—conduct disorder	0.0154	0.205	CbGeAlD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—EP300—conduct disorder	0.015	0.0191	CbGpPWpGaD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—EP300—conduct disorder	0.0141	0.0181	CbGpPWpGaD
Olopatadine—S100A13—brain—conduct disorder	0.0137	0.181	CbGeAlD
Olopatadine—S100A12—brain—conduct disorder	0.0135	0.179	CbGeAlD
Olopatadine—S100B—brain—conduct disorder	0.0133	0.177	CbGeAlD
Olopatadine—S100A12—Innate Immune System—POLR3A—conduct disorder	0.013	0.0166	CbGpPWpGaD
Olopatadine—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.013	0.0166	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—conduct disorder	0.0128	0.0164	CbGpPWpGaD
Olopatadine—Acepromazine—HTR2A—conduct disorder	0.0124	0.0867	CrCbGaD
Olopatadine—S100B—Innate Immune System—POLR3A—conduct disorder	0.0123	0.0157	CbGpPWpGaD
Olopatadine—Clomipramine—SLC6A4—conduct disorder	0.0123	0.0857	CrCbGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—conduct disorder	0.0121	0.0155	CbGpPWpGaD
Olopatadine—Nortriptyline—SLC6A4—conduct disorder	0.012	0.0838	CrCbGaD
Olopatadine—Thiothixene—HTR2A—conduct disorder	0.0119	0.0833	CrCbGaD
Olopatadine—S100A12—Innate Immune System—WASF1—conduct disorder	0.0109	0.014	CbGpPWpGaD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0109	0.014	CbGpPWpGaD
Olopatadine—Doxepin—SLC6A4—conduct disorder	0.0107	0.0752	CrCbGaD
Olopatadine—S100B—Innate Immune System—WASF1—conduct disorder	0.0103	0.0132	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MB21D1—conduct disorder	0.0103	0.0132	CbGpPWpGaD
Olopatadine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0101	0.0129	CbGpPWpGaD
Olopatadine—S100B—Immune System—MB21D1—conduct disorder	0.00974	0.0125	CbGpPWpGaD
Olopatadine—Clomipramine—HTR2A—conduct disorder	0.00942	0.0659	CrCbGaD
Olopatadine—Chlorprothixene—HTR2A—conduct disorder	0.00937	0.0656	CrCbGaD
Olopatadine—Nortriptyline—HTR2A—conduct disorder	0.0092	0.0644	CrCbGaD
Olopatadine—Imipramine—SLC6A4—conduct disorder	0.00836	0.0585	CrCbGaD
Olopatadine—Amitriptyline—SLC6A4—conduct disorder	0.00831	0.0581	CrCbGaD
Olopatadine—Doxepin—HTR2A—conduct disorder	0.00826	0.0578	CrCbGaD
Olopatadine—S100A12—Immune System—POLR3A—conduct disorder	0.00756	0.00967	CbGpPWpGaD
Olopatadine—S100B—Immune System—POLR3A—conduct disorder	0.00715	0.00914	CbGpPWpGaD
Olopatadine—Imipramine—HTR2A—conduct disorder	0.00643	0.045	CrCbGaD
Olopatadine—Amitriptyline—HTR2A—conduct disorder	0.00639	0.0447	CrCbGaD
Olopatadine—S100A12—Immune System—WASF1—conduct disorder	0.00636	0.00814	CbGpPWpGaD
Olopatadine—S100B—Immune System—WASF1—conduct disorder	0.00602	0.0077	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00587	0.00751	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CGA—conduct disorder	0.00485	0.00621	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.00464	0.00593	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.00447	0.00572	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—WASF1—conduct disorder	0.00389	0.00498	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00384	0.00491	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00329	0.00421	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00324	0.00414	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00311	0.00397	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0029	0.00371	CbGpPWpGaD
Olopatadine—HRH1—brain—conduct disorder	0.00273	0.0362	CbGeAlD
Olopatadine—S100B—Signaling Pathways—DRD4—conduct disorder	0.00272	0.00348	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—EP300—conduct disorder	0.00264	0.00338	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.00253	0.00323	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0025	0.0032	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.0025	0.0032	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EP300—conduct disorder	0.0025	0.00319	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00229	0.00294	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00215	0.00274	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2A—conduct disorder	0.00177	0.00227	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00166	0.00213	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00165	0.00211	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00164	0.0021	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	0.00163	0.00209	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EP300—conduct disorder	0.00154	0.00197	CbGpPWpGaD
Olopatadine—S100B—Immune System—EP300—conduct disorder	0.00145	0.00186	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	0.00142	0.00181	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CGA—conduct disorder	0.00136	0.00173	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—DRD4—conduct disorder	0.00129	0.00164	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—WASF1—conduct disorder	0.00109	0.00139	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EP300—conduct disorder	0.00094	0.0012	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	0.000923	0.00118	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	0.000839	0.00107	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DRD4—conduct disorder	0.000759	0.000971	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CGA—conduct disorder	0.00063	0.000805	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2A—conduct disorder	0.000495	0.000634	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—COMT—conduct disorder	0.000284	0.000364	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000282	0.000361	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EP300—conduct disorder	0.000262	0.000336	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—EP300—conduct disorder	0.000122	0.000156	CbGpPWpGaD
